Anti-inflammatory effects of resveratrol in lung epithelial cells: Molecular mechanisms

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 287, Issue 4 31-4, 2004, Pages

  Donnelly, Louise E ^a   Newton, Robert ^a   Kennedy, Gina E ^a   Fenwick, Peter S ^a   Leung, Rachel H F ^a   Ito, Kazuhiro ^a   Russell, Richard E K ^a   Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Inducible nitric oxide synthase; Quercetin; Red wine

Indexed keywords

ACETYLCYSTEINE; CYCLIC AMP; CYCLOOXYGENASE 2; DEOXYRHAPONTIN; DEXAMETHASONE; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ANTAGONIST; GLUCOCORTICOID; GLUCOCORTICOID ANTAGONIST; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GW 466471; HISTONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MIFEPRISTONE; NITRIC OXIDE SYNTHASE; NITRITE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA ANTAGONIST; PIRINIXIC ACID; PROTEIN INHIBITOR; QUERCETIN; RESVERATROL; RHAPONTIN; TAMOXIFEN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ACETYLATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; DEACETYLATION; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SECRETION; REPORTER GENE; STATISTICAL SIGNIFICANCE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL CULTURE TECHNIQUES; CELL LINE; DEXAMETHASONE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INFLAMMATION; KINETICS; LUNG; QUERCETIN; RESPIRATORY MUCOSA; STILBENES; TRANSFECTION;

EID: 4544310412     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00110.2004     Document Type: Article

References (48)

1. Abou-Agag LH, Aikens ML, Tabengwa EM, Benza RL, Shows SR, Grenett HE, and Booyse FM. Polyphenolics increase t-PA and u-PA gene transcription in cultured human endothelial cells. Alcohol Clin Exp Res 25: 155-162, 2001.
2. Ahn KS, Kim JH, Oh SR, Ryu SY, and Lee HK. Inhibitory activity of stilbenes from medicinal plants on the expression of cell adhesion molecules on THP1 cells. Planta Med 66: 641-644, 2000.
3. Bergmann M, Hart L, Lindsay M, Barnes PJ, and Newton R. IκBα degradation and nuclear factor-κB DNA binding are insufficient for interleukin-1β- and tumor necrosis factor-α-induced κB-dependent transcription. Requirement for an additional activation pathway. J Biol Chem 273: 6607-6610, 1998.
4. Blackwell TS and Christman JW. The role of nuclear factor-κB in cytokine gene regulation. Am J Respir Cell Mol Biol 17: 3-9, 1997.
5. Caltagirone S, Ranelletti FO, Rinelli A, Maggiano N, Colasante A, Musiani P, Aiello FB, and Piantelli M. Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small-cell lung cancer. Am J Respir Cell Mol Biol 17: 51-59, 1997.
6. Casper RF, Quesne M, Rogers IM, Shirota T, Jolivet A, Milgrom E, and Savouret JF. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. J Histochem Cytochem 56: 784-790, 1999.
7. 2 release via the expression of cyclooxygenase-2 and microsomal prostaglandin E synthase. FEBS Lett 547: 75-79, 2003.
8. Ciolino HP and Yeh GC. Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. J Histochem Cytochem 56: 760-767, 1999.
9. Croxtall JD, Choudhury Q, White JO, and Flower RJ. Tamoxifen inhibits the release of arachidonic acid stimulated by thapsigargin in estrogen receptor-negative A549 cells. Biochim Biophys Acta 1349: 275-284, 1997.
10. Croxtall JD, Emmas C, White JO, Choudhary Q, and Flower RJ. Tamoxifen inhibits growth of oestrogen receptor-negative A549 cells. Biochem Pharmacol 47: 197-202, 1994.
11. Culpitt SV, Maziak W, Loukidis S, Nightingale JA, Matthews JL, and Barnes PJ. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160: 1635-1639, 1999.
12. Culpitt SV, Rogers DF, Fenwick PS, Shah P, De Matos C, Russell RE, Barnes PJ, and Donnelly LE. Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax 58: 942-946, 2003.
13. Culpitt SV, Rogers DF, Shah P, De Matos C, Russell RE, Donnelly LE, and Barnes PJ. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167: 24-31, 2003.
14. 4 production by N-acetylcysteine: role of hydrogen peroxide. Br J Pharmacol 122: 758-764, 1997.
15. Donnelly LE and Barnes PJ. Expression of heme oxygenase in human airway epithelial cells. Am J Respir Cell Mol Biol 24: 295-303, 2001.
16. Donnelly LE and Barnes PJ. Expression and regulation of inducible nitric oxide synthase from human primary airway epithelial cells. Am J Respir Cell Mol Biol 26: 144-151, 2002.
17. ElAttar TM and Viril AS. Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation. Anticancer Drugs 10: 187-193, 1999.
18. El Mowafy AM and Alkhalaf M. Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism. Carcinogenesis 24: 869-873, 2003.
19. Fremont L. Biological effects of resveratrol. Life Sci 66: 663-673, 2000.
20. Gehm BD, McAndrews JM, Chien PY, and Jameson JL. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 94: 14138-14143, 1997.
21. German JB and Walzem RL. The health benefits of wine. Annu Rev Nutr 20: 561-593, 2000.
22. Goldberg DM, Karumanchiri A, Ng E, Yan J, Diamandis EP, and Soleas GJ. Direct gas chromatographic-mass spectrometric method to assay cis-resveratrol in wines: preliminary survey of its concentration in commercial wines. J Agric Food Chem 43: 1245-1250, 1995.
23. 5 receptors expressed in stable cAMP-responsive luciferase reporter cell lines. J Recept Res 13: 79-94, 1993.
24. Holmes MM and Baldwin ASJ. Chemopreventive properties of transresveratrol are associated with inhibition of activation of the IκB kinase. Cancer Res 60: 3477-3483, 2000.
25. Huang N, Katz JP, Martin DR, and Wu GD. Inhibition of IL-8 gene expression in Caco-2 cells by compounds which induce histone hyperacetylation. Cytokine 9: 27-36, 1997.
26. Inoue H, Jiang XF, Katayama T, Osada S, Umesono K, and Namura S. Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor-α in mice. Neurosci Lett 352: 203-206, 2003.
27. Ito K, Barnes PJ, and Adcock IM. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1β-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 20: 6891-6903, 2000.
28. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, and Pezzuto JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220, 1997.
29. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270: 16483-16486, 1995.
30. Kawada N, Seki S, Inoue M, and Kuroki T. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology 27: 1265-1274, 1998.
31. Leung DY and Szefler SJ. New insights into steroid-resistant asthma. Pediatr Allergy Immunol 9: 3-12, 1998.
32. LeVan TD, Babin EA, Yamamura HI, and Bloom JW. Pharmacological characterization of glucocorticoid receptors in primary human bronchial epithelial cells. Biochem Pharmacol 57: 1003-1009, 1999.
33. Lu R and Serrero G. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J Cell Physiol 179: 297-304, 1999.
34. Manna SK, Mukhopadhyay A, and Aggarwal BB. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κB, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 164: 6509-6519, 2000.
35. Martinez J and Moreno JJ. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol 59: 865-870, 2000.
36. Matsuda H, Kageura T, Morikawa T, Toguchida I, Harima S, and Yoshikawa M. Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages. Bioorg Med Chem Lett 10: 323-327, 2000.
37. Misko TP, Schilling RJ, Salvemini D, Moore WM, and Currie MG. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 214: 11-16, 1993.
38. Newton R. Molecular mechanisms of glucocorticoid action: what is important? Thorax 55: 603-613, 2000.
39. Newton R, Kuitert LM, Bergmann M, Adcock IM, and Barnes PJ. Evidence for involvement of NF-κB in the transcriptional control of COX-2 gene expression by IL-1β. Biochem Biophys Res Commun 237: 28-32, 1997.
40. 2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells. Life Sci 60: 67-78, 1997.
41. 2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA. J Biol Chem 273: 32312-32321, 1998.
42. Subbaramaiah K, Chung WJ, Michaluart P, Telang N, Tanabe T, Inoue H, Jang M, Pezzuto JM, and Dannenberg AJ. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 273: 21875-21882, 1998.
43. Sun AY, Simonyi A, and Sun GY. The "French paradox" and beyond: neuroprotective effects of polyphenols(1,2). Free Radic Biol Med 32: 314-318, 2002.
44. Szewczuk LM, Forti L, Stivala LA, and Penning TM. Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1-selective agents. J Biol Chem 279: 22727-22737, 2004.
45. Tsai SH, Lin-Shiau SY, and Lin JK. Suppression of nitric oxide synthase and the down-regulation of the activation of NFκB in macrophages by resveratrol. Br J Pharmacol 126: 673-680, 1999.
46. Vayssiere BM, Dupont S, Choquart A, Petit F, Garcia T, Marchandeau C, Gronemeyer H, and Resche-Rigon M. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit anti-inflammatory activity in vivo. Mol Endocrinol 11: 1245-1255, 1997.
47. Wadsworth TL and Koop DR. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem Pharmacol 57: 941-949, 1999.
48. Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, Cobb JE, McKee DD, Galardi CM, Plunket KD, Nolte RT, Parks DJ, Moore JT, Kliewer SA, Willson TM, and Stimmel JB. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARα. Nature 415: 813-817, 2002.